Examinando por Autor "Moreira-Soto, Andrés"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    Ítem
    Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19
    (Los autores, 2021-09) Sánchez, Andrés; Alape-Girón, Alberto; Moreira-Soto, Andrés; Arguedas, Mauricio; Brenes, Hebleen; Buján, Willem; Corrales-Aguilar, Eugenia; Díaz, Cecilia; Echeverri, Ann; Flores-Díaz, Marietta; Gómez, Aarón; Hernández, Andrés; Herrera, María; León, Guillermo; Macaya, Román; Molina-Mora, José Arturo; Mora, Javier; Narayanan, Aarthi; Sanabria, Alfredo; Sánchez, Laura; Segura, Álvaro; Segura, Eduardo; Solano, Daniela; Soto, Claudio; Stynoski, Jennifer L; Vargas, Mariángela; Villalta, Mauren; Drexler, Jan Felix; Gutiérrez, José María
    The emergence and dissemination of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting COVID-19 pandemic triggered a global public health crisis. Although several SARS-CoV-2 vaccines have been developed, demand far exceeds supply, access to them is inequitable, and thus, populations in low- and middle-income countries are unlikely to be protected soon (1). Furthermore, there are no specific therapies available, which is a challenge for COVID-19 patient care (2). Thus, the appearance of SARS-CoV-2 variants and reports of reinfections associated with immune escape (3, 4) highlight the urgent need for effective and broad coverage COVID-19 therapeutics